133 related articles for article (PubMed ID: 8600312)
1. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21).
Nabarra B; Casanova M; Paris D; Nicole A; Toyama K; Sinet PM; Ceballos I; London J
Lab Invest; 1996 Mar; 74(3):617-26. PubMed ID: 8600312
[TBL] [Abstract][Full Text] [Related]
2. Early thymic T cell development in young transgenic mice overexpressing human Cu/Zn superoxide dismutase, a model of Down syndrome.
Laurent J; Paly E; Marche PN; London J
Free Radic Biol Med; 2006 Jun; 40(11):1971-80. PubMed ID: 16716898
[TBL] [Abstract][Full Text] [Related]
3. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
Groner Y; Elroy-Stein O; Avraham KB; Yarom R; Schickler M; Knobler H; Rotman G
J Physiol (Paris); 1990; 84(1):53-77. PubMed ID: 1972759
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse, a murine model for human Down's syndrome.
Paz-Miguel JE; Flores R; Sánchez-Velasco P; Ocejo-Vinyals G; Escribano de Diego J; López de Rego J; Leyva-Cobián F
J Immunol; 1999 Nov; 163(10):5399-410. PubMed ID: 10553065
[TBL] [Abstract][Full Text] [Related]
5. Premature thymic involution, observed at the ultrastructural level, in two lineages of human-SOD-1 transgenic mice.
Nabarra B; Casanova M; Paris D; Paly E; Toyoma K; Ceballos I; London J
Mech Ageing Dev; 1997 Jun; 96(1-3):59-73. PubMed ID: 9223111
[TBL] [Abstract][Full Text] [Related]
6. Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein [correction].
Harris-Cerruti C; Kamsler A; Kaplan B; Lamb B; Segal M; Groner Y
Eur J Neurosci; 2004 Mar; 19(5):1174-90. PubMed ID: 15016076
[TBL] [Abstract][Full Text] [Related]
7. Radiation sensitivity of Down's syndrome fibroblasts might be due to overexpressed Cu/Zn-superoxide dismutase (EC 1.15.1.1).
Schwaiger H; Weirich HG; Brunner P; Rass C; Hirsch-Kauffmann M; Groner Y; Schweiger M
Eur J Cell Biol; 1989 Feb; 48(1):79-87. PubMed ID: 2526018
[TBL] [Abstract][Full Text] [Related]
8. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
Annerén G; Edman B
APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
[TBL] [Abstract][Full Text] [Related]
9. [Dosage effect of the cytoplasmic superoxide dismutase (SOD-1) gene in the erythrocytes of Down's syndrome patients].
Tamarkina AD; Annenkov GA; Filippov IK; Lamchingiĭn T
Genetika; 1977; 13(5):929-32. PubMed ID: 147797
[TBL] [Abstract][Full Text] [Related]
10. Increased superoxide dismutase and Down's syndrome.
Turrens JF
Med Hypotheses; 2001 Jun; 56(6):617-9. PubMed ID: 11399108
[TBL] [Abstract][Full Text] [Related]
11. The role of zinc in pre- and postnatal mammalian thymic immunohistogenesis.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1998; 12(6):695-722. PubMed ID: 9891234
[TBL] [Abstract][Full Text] [Related]
12. Clinical symptoms of Down syndrome are manifested in transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
Groner Y; Avraham KB; Schickler M; Yarom R; Knobler H
Prog Clin Biol Res; 1990; 360():233-62. PubMed ID: 2147288
[No Abstract] [Full Text] [Related]
13. Evaluation of superoxide dismutase and glutathione peroxidase enzymes and their cofactors in Egyptian children with Down's syndrome.
Meguid NA; Kholoussi NM; Afifi HH
Biol Trace Elem Res; 2001 Jul; 81(1):21-8. PubMed ID: 11508329
[TBL] [Abstract][Full Text] [Related]
14. DNA fragmentation and Prolonged expression of c-fos, c-jun, and hsp70 in kainic acid-induced neuronal cell death in transgenic mice overexpressing human CuZn-superoxide dismutase.
Kondo T; Sharp FR; Honkaniemi J; Mikawa S; Epstein CJ; Chan PH
J Cereb Blood Flow Metab; 1997 Mar; 17(3):241-56. PubMed ID: 9119897
[TBL] [Abstract][Full Text] [Related]
15. Cell damage by excess CuZnSOD and Down's syndrome.
Groner Y; Elroy-Stein O; Avraham KB; Schickler M; Knobler H; Minc-Golomb D; Bar-Peled O; Yarom R; Rotshenker S
Biomed Pharmacother; 1994; 48(5-6):231-40. PubMed ID: 7999984
[TBL] [Abstract][Full Text] [Related]
16. Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome.
Ceballos I; Nicole A; Briand P; Grimber G; Delacourte A; Flament S; Blouin JL; Thevenin M; Kamoun P; Sinet PM
Free Radic Res Commun; 1991; 12-13 Pt 2():581-9. PubMed ID: 1829430
[TBL] [Abstract][Full Text] [Related]
17. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
[TBL] [Abstract][Full Text] [Related]
18. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome.
Ceballos-Picot I; Nicole A; Briand P; Grimber G; Delacourte A; Defossez A; Javoy-Agid F; Lafon M; Blouin JL; Sinet PM
Brain Res; 1991 Jun; 552(2):198-214. PubMed ID: 1717112
[TBL] [Abstract][Full Text] [Related]
19. Involution of the mammalian thymus, one of the leading regulators of aging.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1997; 11(5):421-40. PubMed ID: 9427047
[TBL] [Abstract][Full Text] [Related]
20. Increased heart rate variability in mice overexpressing the Cu/Zn superoxide dismutase.
Thireau J; Poisson D; Zhang BL; Gillet L; Le Pécheur M; Andres C; London J; Babuty D
Free Radic Biol Med; 2008 Aug; 45(4):396-403. PubMed ID: 18513493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
